Atrial Fibrillation: An Update for Home Healthcare Clinicians.
Level 5 - mechanism / opinion, no new human data
Narrative clinical review summarizing practice guidelines without systematic search methodology.
PubMed 33417356 · doi:10.1097/NHH.0000000000000946
What was done
This paper reviews the American College of Cardiology and American Heart Association (ACC/AHA) Task Force on Clinical Practice Guidelines for atrial fibrillation management and translates key recommendations for home healthcare clinicians.
What was found
The abstract reports that atrial fibrillation affects 2.7 to 6.1 million individuals in the United States and outlines standard management priorities (stroke-risk reduction, heart rate control, rhythm management, and prevention of cardiac-related morbidity and mortality). No original experimental data or quantitative study outcomes are reported in the abstract.
Why it matters
It provides practical guideline-based recommendations to help home healthcare clinicians identify risks, support rate/rhythm management, and prevent thromboembolic stroke in home-bound patients.
Limits
As a narrative review, it contains no original empirical human data, no systematic literature search methodology, and no statistical analyses.
Cited by
- supports Atrial fibrillation forms clots in the upper chambers of the heart, which can then travel into the lower chambers and be pumped to the brain.